Optimal Management of High-Risk T1G3 Bladder Cancer: A Decision Analysis
Author Information
Author(s): Girish S. Kulkarni, Antonio Finelli, Neil E. Fleshner, Michael A. Jewett, Steven R. Lopushinsky, Shabbir M. H. Alibhai
Primary Institution: University of Toronto
Hypothesis
What is the optimal treatment strategy for high-risk T1G3 bladder cancer?
Conclusion
Younger patients with high-risk T1G3 bladder cancer have a higher life expectancy and quality-adjusted life expectancy with immediate cystectomy compared to conservative therapy.
Supporting Evidence
- The model predicted that immediate cystectomy provided a mean life expectancy of 14.3 years compared to 13.6 years with conservative management.
- Immediate cystectomy was preferred by 0.35 quality-adjusted life years over conservative therapy.
- Patients over age 70 or those averse to loss of sexual function may benefit from conservative therapy.
Takeaway
Doctors looked at two ways to treat a type of bladder cancer and found that younger patients might live longer and feel better if they have surgery right away instead of waiting.
Methodology
A decision-analytic Markov model was used to compare immediate cystectomy with conservative management for high-risk T1G3 bladder cancer.
Potential Biases
Potential selection biases from the studies used to derive probabilities.
Limitations
The study relied on retrospective data and expert opinion for some probabilities and utilities, which may introduce bias.
Participant Demographics
The base case was a 60-year-old, otherwise healthy, sexually potent male.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website